Zylö Therapeutics
Greenville
About Zylö Therapeutics
Zylö Therapeutics offers an innovative sustained-release drug-delivery system that was developed by Joel Friedman MD PhD, Adam Friedman MD FAAD, and Andrew Draganski PhD. The delivery system uses patented hydrogel-derived nanoparticles, called Nanopods, to deliver’in a sustained and controlled manner’notoriously hard-to-deliver therapeutic agents through topical administration. The company was founded in 2017 and is based in Greenville, South Carolina.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.5M
- Funding stage: Early Stage Venture
- Last round: Grant (May 2023)
- Website: zylotherapeutics.com
- Phone: 858.775.6710
Industries & Categories
Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/zyl-therapeutics-50311 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.